A plant-based expression system could provide greater speed and capacity at a comparatively low cost.
Frédéric Ors
Advertisement
Frédéric Ors is vice-president of business development at Medicago
Articles by Frédéric Ors
Advertisement
Latest Updated Articles
Plants As an Innovative and Accelerated Vaccine-Manufacturing SolutionPublished: May 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
